ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 226.8% in November

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a significant growth in short interest in November. As of November 15th, there was short interest totalling 81,700 shares, a growth of 226.8% from the October 31st total of 25,000 shares. Based on an average daily volume of 225,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 12.4% of the company’s stock are short sold.

ReShape Lifesciences Stock Up 1.2 %

Shares of NASDAQ:RSLS traded up $0.07 during trading on Thursday, reaching $5.75. The stock had a trading volume of 30,523 shares, compared to its average volume of 99,179. The firm’s 50-day simple moving average is $5.64 and its 200 day simple moving average is $9.24. ReShape Lifesciences has a one year low of $4.60 and a one year high of $34.22.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.